AAAAAA
Results: 1-25/33
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Individualizing target haemoglobin concentrations - tailoring treatment for renal anaemia, NEPH DIAL T, 16, 2001, pp. 9-14
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Intravenous administration of iron in epoetin-treated haemodialysis patients - Reply, NEPH DIAL T, 16(5), 2001, pp. 1077-1077
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Present and future strategies in the treatment of renal anaemia, NEPH DIAL T, 16, 2001, pp. 50-55
Authors:
Macdougall, IC
Citation: Ic. Macdougall, An overview of the efficacy and safety of novel erythropoiesis stimulatingprotein (NESP), NEPH DIAL T, 16, 2001, pp. 14-21
Authors:
Aljama, P
Bommer, J
Canaud, B
Carrera, F
Eckardt, KU
Horl, WH
Kredict, RT
Locatelli, F
Macdougall, IC
Wikstrom, B
Citation: P. Aljama et al., Practical guidelines for the use of NESP in treating renal anaemia, NEPH DIAL T, 16, 2001, pp. 22-28
Authors:
Chandler, G
Harchowal, J
Macdougall, IC
Citation: G. Chandler et al., Intravenous iron sucrose: Establishing a safe dose, AM J KIDNEY, 38(5), 2001, pp. 988-991
Authors:
Macdougall, IC
Citation: Ic. Macdougall, ACE inhibitors and erythropoietin responsiveness, AM J KIDNEY, 38(3), 2001, pp. 649-651
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Should the hematocrit be normalized in dialysis and in pre-ESRD patients?, BLOOD PURIF, 19(2), 2001, pp. 157-167
Authors:
Bosman, DR
Winkler, AS
Marsden, JT
Macdougall, IC
Watkins, PJ
Citation: Dr. Bosman et al., Anemia with erythropoietin deficiency occurs early in diabetic nephropathy, DIABET CARE, 24(3), 2001, pp. 495-499
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Role of uremic toxins in exacerbating anemia in renal failure, KIDNEY INT, 59, 2001, pp. S67-S72
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Darbepoetin alfa - A viewpoint, DRUGS, 61(14), 2001, pp. 2106-2106
Authors:
Valderrabano, F
Horl, WH
Jacobs, C
Macdougall, IC
Citation: F. Valderrabano et al., European Survey on Anaemia Management (ESAM) - Foreword, NEPH DIAL T, 15, 2000, pp. 1-1
Authors:
Valderrabano, F
Horl, WH
Jacobs, C
Macdougall, IC
Parrondo, I
Manhaeve, D
Milisen, K
Citation: F. Valderrabano et al., European Survey on Anaemia Management (ESAM) - Patients and methods, NEPH DIAL T, 15, 2000, pp. 2-7
Authors:
Valderrabano, F
Horl, WH
Jacobs, C
Macdougall, IC
Parrondo, I
Cremers, S
Abraham, IL
Citation: F. Valderrabano et al., European Best Practice Guidelines 1-4 - Evaluating anaemia and initiating treatment, NEPH DIAL T, 15, 2000, pp. 8-14
Authors:
Jacobs, C
Horl, WH
Macdougall, IC
Valderrabano, F
Parrondo, I
Segner, A
Abraham, IL
Citation: C. Jacobs et al., European Best Practice Guidelines 5 - Target haemoglobin, NEPH DIAL T, 15, 2000, pp. 15-19
Authors:
Macdougall, IC
Horl, WH
Jacobs, C
Valderrabano, F
Parrondo, I
Thompson, K
Cremers, S
Citation: Ic. Macdougall et al., European Best Practice Guidelines 6-8 - Assessing and optimizing iron stores, NEPH DIAL T, 15, 2000, pp. 20-32
Authors:
Jacobs, C
Horl, WH
Macdougall, IC
Valderrabano, F
Parrondo, I
Abraham, IL
Segner, A
Citation: C. Jacobs et al., European Best Practice Guidelines 9-13 - Anaemia management, NEPH DIAL T, 15, 2000, pp. 33-42
Authors:
Horl, WH
Jacobs, C
Macdougall, IC
Valderrabano, F
Parrondo, I
Thompson, K
Carveth, BG
Citation: Wh. Horl et al., European Best Practice Guidelines 14-16 - Inadequate response to epoetin, NEPH DIAL T, 15, 2000, pp. 43-50
Authors:
Horl, WH
Jacobs, C
Macdougall, IC
Valderrabano, F
Parrondo, I
Carveth, BG
Thompson, K
Citation: Wh. Horl et al., European Best Practice Guidelines 17-18 - Adverse effects, NEPH DIAL T, 15, 2000, pp. 51-56
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Higher target haemoglobin level and early anaemia treatment: different or complementary concepts?, NEPH DIAL T, 15, 2000, pp. 3-7
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Intravenous administration of iron in epoetin-treated haemodialysis patients - which drugs, which regimen?, NEPH DIAL T, 15(11), 2000, pp. 1743-1745
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Novel erythropoiesis stimulating protein, SEM NEPHROL, 20(4), 2000, pp. 375-381
Authors:
Macdougall, IC
Citation: Ic. Macdougall, How to improve survival in pre-dialysis patients, NEPHRON, 85, 2000, pp. 15-22
Authors:
Allen, DA
Breen, C
Yaqoob, MM
Macdougall, IC
Citation: Da. Allen et al., Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: Role of IFN-gamma and TNF-alpha, J INVES MED, 47(5), 1999, pp. 204-211
Authors:
Macdougall, IC
Gray, SJ
Elston, O
Breen, C
Jenkins, B
Browne, J
Egrie, J
Citation: Ic. Macdougall et al., Pharmacokinetics of novel erythropoiesis stimulating protein compared withepoetin alfa in dialysis patients, J AM S NEPH, 10(11), 1999, pp. 2392-2395